BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the selection of ...
Insight Molecular Diagnostics Inc., (NASDAQ: IMDX) shares enjoyed strong gains at first Monday, on providing a year-end business update regarding its commercial progress, its GraftAssureDx™ test kit ...
GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...
GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Dr Maryam Ahmed Almustapha, an Abuja-based specialist, who has highlighted the alarming consequences of beating and physical abuse on pregnant women.
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
OHSU radiation oncologist presents promising study findings, launches a third, Medicare-backed study Nima Nabavizadeh, M.D., ...
The false negative rates do not appear out of line with the test's sensitivity figures, but issues have been raised with its workflow and the firm's marketing strategy.
This important work provides a new method to extract cfDNA from residual plasma from heparin separators for molecular testing. The evidence supporting the authors' claims is convincing, although some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback